Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective 3-Year Follow-up Study in Subjects Previously Treated in a Phase IIb or Phase III Study With a TMC435-Containing Regimen for the Treatment of Hepatitis C Virus (HCV) Infection

NCT01349465 is registered in ClinicalTrials.gov with Janssen R&D Ireland as lead sponsor.

NCT NCT01349465
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01349465 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective 3-Year Follow-up Study in Subjects Previously Treated in a Phase IIb or Phase III Study With a TMC435-Containing Regimen for the Treatment of Hepatitis C Virus (HCV) Infection
Lead sponsor
Janssen R&D Ireland
Phase
Phase 3
Overall status
Completed
Start date
July 4, 2011
Completion date
January 5, 2016
Enrollment
249 (actual)
Sites
48

Conditions

As the registry lists them; a condition with its own page is linked.

hepatitis c